Joyce Hui-Yuen, MD, MS
North Shore LIJ Health System
Great Neck, NY, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Ekemini Ogbu, MD, MSc
Cincinnati Children's Hospital Medical Center
Cincinnati, OH, United States
Disclosure information not submitted.
Ekemini Ogbu, MD, MSc
Cincinnati Children's Hospital Medical Center
Cincinnati, OH, United States
Disclosure information not submitted.
Joyce Hui-Yuen, MD, MS
North Shore LIJ Health System
Great Neck, NY, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Pediatric systemic lupus erythematosus is characterized by periods of flare and remission. Corticosteroids have often been the mainstay of treatment of flare and maintenance of disease remission. However, chronic corticosteroid use places patients at higher risk for development of severe long-term side effects such as osteoporosis, growth delay, cataracts, and avascular necrosis. Thus, long term use of corticosteroids, even at low doses, in pediatric lupus patients is a topic of controversy. Two speakers will discuss available data on definitions of low disease activity and disease remission and debate the benefits and timeframe for continuing vs. discontinuing corticosteroids in pediatric lupus patients.
Speaker: Emily von Scheven, MD – University of California, San Francisco
Speaker: Hermine Brunner, MD, MSc, MBA – Cincinnati Children's Hospital Medical Center
